PERSONALISED MEDICINE
EMPOWERMENT
CONNECTING INNOVATION ECOSYSTEMS ACROSS EUROPE
Embedded Files
PRECISEU connects innovation ecosystems across Europe to advance personalised healthcare, share practices and solutions across regions, and scale deep-tech healthcare innovations based on advanced therapies, medicinal products, and health data.
PRECISEU connects innovation ecosystems across Europe to advance personalised healthcare, share practices and solutions across regions, and scale deep-tech healthcare innovations based on advanced therapies, medicinal products, and health data.
The 3rd edition of the PM School will mentor ecosystem stakeholders to bring health-data and ATMP innovations to market, foster a deep-tech culture and its adoption in healthcare, and recognise leading practices across regions.
The 3rd edition of the PM School will mentor ecosystem stakeholders to bring health-data and ATMP innovations to market, foster a deep-tech culture and its adoption in healthcare, and recognise leading practices across regions.
About the Personalised Medicine School
About the Personalised Medicine School
The PRECISEU Personalised Medicine Schools are an annual gathering for key stakeholders in personalised medicine. They are designed to help students, professionals, and entrepreneurs build skills and gain new knowledge in a focused, high-impact programme.
The PRECISEU Personalised Medicine Schools are an annual gathering for key stakeholders in personalised medicine. They are designed to help students, professionals, and entrepreneurs build skills and gain new knowledge in a focused, high-impact programme.
The third edition expands the format from short lunch webinars into a full five-day hybrid programme — combining live sessions in Sofia with online participation across Europe — covering the full lifecycle from regulation and ATMPs to funding, infrastructure, IPR, and skills.
The third edition expands the format from short lunch webinars into a full five-day hybrid programme — combining live sessions in Sofia with online participation across Europe — covering the full lifecycle from regulation and ATMPs to funding, infrastructure, IPR, and skills.
Engaging Formats Include
Engaging Formats Include
• Hybrid in-person + online live sessions, with recordings available after each day
• Hybrid in-person + online live sessions, with recordings available after each day
• Keynote talks from European leaders, including the European Medicines Agency (EMA), EATRIS, EIT Health, Merck, the University of Bologna and many others
• Keynote talks from European leaders, including the European Medicines Agency (EMA), EATRIS, EIT Health, Merck, the University of Bologna and many others
• Workshops on investment readiness, dual-use compliance, and IPR
• Workshops on investment readiness, dual-use compliance, and IPR
• Hands-on lab demonstrations at the BioRed Lab
• Hands-on lab demonstrations at the BioRed Lab
• Cross-regional dialogue with the PRECISEU consortium (26 partners) and the Spinoff Initiative ecosystem
• Cross-regional dialogue with the PRECISEU consortium (26 partners) and the Spinoff Initiative ecosystem
Why Join
Why Join
Gain insights into cutting-edge European initiatives and regional partnerships.
Understand the opportunities and challenges of ATMPs and data-driven personalised medicine
Learn how health data and AI enable discovery, validation, and scale-up
Acquire early exposure to innovation, investment, and spinoff pathways
Become part of the Spinoff EUROPA 2026 innovation community.
- Participants who take part in at least three of the five sessions will receive a certificate acknowledging their dedication to learning and expanding their insights in personalised medicine.
Participants attending at least three sessions will receive a certificate of participation, recognising their commitment to advancing personalised medicine competencies.
Join us in Sofia to shape the next generation of personalised medicine—where science, data, and innovation turn into real impact!
Daily Programme · Sessions and Registration
Daily Programme · Sessions and Registration
Friday, 5 June 2026 (14:00 – 18:00 CET)
Friday, 5 June 2026 (14:00 – 18:00 CET)
The opening day will focus on the European personalised medicine ecosystem, covering EHDS, FAIR data, interoperability, research data management, AI-driven healthcare innovation, and virtual twins in personalised care pathways.
The opening day will focus on the European personalised medicine ecosystem, covering EHDS, FAIR data, interoperability, research data management, AI-driven healthcare innovation, and virtual twins in personalised care pathways.
14:00 Opening, welcome and PRECISEU Personalised Medicine School overview — PRECISEU Coordination (Live)
14:20 EHDS and new European legislation for personalised medicine — Christian Dierks · Dierks & Company (Online)
15:00 Virtual twins and personalised care pathways — Victòria Valls (AQuAS) · Laura Escot (Vall d’Hebron Hospital, Barcelona) · Davide Cirillo (Online)
16:00 Short break
16:20 Interoperability frameworks and FAIR data in personalised medicine — Laura Portell (TBC) (Online)
16:50 Data Management Plans and research data management practices — Aída Moure (Online)
17:20 ELSI guidelines developed within PRECISEU WP3 — Tomás Muñoz (Online)
17:50–18:00 Wrap-up & Q&A — PRECISEU Coordination (Live)
14:00 Opening, welcome and PRECISEU Personalised Medicine School overview — PRECISEU Coordination (Live)
14:20 EHDS and new European legislation for personalised medicine — Christian Dierks · Dierks & Company (Online)
15:00 Virtual twins and personalised care pathways — Victòria Valls (AQuAS) · Laura Escot (Vall d’Hebron Hospital, Barcelona) · Davide Cirillo (Online)
16:00 Short break
16:20 Interoperability frameworks and FAIR data in personalised medicine — Laura Portell (TBC) (Online)
16:50 Data Management Plans and research data management practices — Aída Moure (Online)
17:20 ELSI guidelines developed within PRECISEU WP3 — Tomás Muñoz (Online)
17:50–18:00 Wrap-up & Q&A — PRECISEU Coordination (Live)
Saturday, 6 June 2026 (14:00 – 18:00 CET)
Saturday, 6 June 2026 (14:00 – 18:00 CET)
The second day will focus on advanced therapy medicinal products (ATMPs), dual-use technologies, European biotech legislation, reimbursement systems, and regulatory frameworks supporting the safe and scalable deployment of personalised medicine innovations.
The second day will focus on advanced therapy medicinal products (ATMPs), dual-use technologies, European biotech legislation, reimbursement systems, and regulatory frameworks supporting the safe and scalable deployment of personalised medicine innovations.
13:30 Welcome and introduction — PRECISEU Coordination (Live)
13:40 Dual-use technologies in biotechnology and AI — export controls and practical compliance for startups — EDIH Cyber4All (Live)
15:00 ATMP-XB Interreg project — QA/QC competence centres and cross-border collaboration for scalable ATMP production — ATMP-XB partners (Online)
15:45 Break and informal networking
16:00 Session to be confirmed (Online)
16:45 Reimbursement systems and the EU Biotech Act — Nerea Blanqué · Alira Health (Online)
17:30–17:40 Wrap-up & Q&A — PRECISEU Coordination (Live)
13:30 Welcome and introduction — PRECISEU Coordination (Live)
13:40 Dual-use technologies in biotechnology and AI — export controls and practical compliance for startups — EDIH Cyber4All (Live)
15:00 ATMP-XB Interreg project — QA/QC competence centres and cross-border collaboration for scalable ATMP production — ATMP-XB partners (Online)
15:45 Break and informal networking
16:00 Session to be confirmed (Online)
16:45 Reimbursement systems and the EU Biotech Act — Nerea Blanqué · Alira Health (Online)
17:30–17:40 Wrap-up & Q&A — PRECISEU Coordination (Live)
Sunday, 7 June 2026 (14:00 – 18:00 CET)
Sunday, 7 June 2026 (14:00 – 18:00 CET)
The third day will focus on European funding instruments, investment readiness, spinoff creation, ESG and dual-use considerations, and strategic pathways for scaling personalised medicine and health innovation projects across Europe.
The third day will focus on European funding instruments, investment readiness, spinoff creation, ESG and dual-use considerations, and strategic pathways for scaling personalised medicine and health innovation projects across Europe.
14:00 Welcome & recap — PRECISEU Coordination (Online)
14:10 Horizon Europe & Digital Europe funding for health innovation — positioning personalised medicine solutions in European programmes (Part 1) — Horizon Europe (Live)
14:50 Horizon Europe & Digital Europe funding deep dive and Q&A (Part 2) — Horizon Europe (Live)
15:30 Break
15:40 Investment readiness for health and biotech spinoffs — pitch preparation, market validation, and financial modelling workshop (Live)
16:15 Critical Infrastructure in Health — Antonia Staykova (Live)
16:45 Digital Health Data Cross-Regional Polygon — GATE Institute · VELES (Live)
17:00–18:00 Wrap-up, discussion & strategic outlook for innovators and regional authorities — PRECISEU Coordination (Live)
14:00 Welcome & recap — PRECISEU Coordination (Online)
14:10 Horizon Europe & Digital Europe funding for health innovation — positioning personalised medicine solutions in European programmes (Part 1) — Horizon Europe (Live)
14:50 Horizon Europe & Digital Europe funding deep dive and Q&A (Part 2) — Horizon Europe (Live)
15:30 Break
15:40 Investment readiness for health and biotech spinoffs — pitch preparation, market validation, and financial modelling workshop (Live)
16:15 Critical Infrastructure in Health — Antonia Staykova (Live)
16:45 Digital Health Data Cross-Regional Polygon — GATE Institute · VELES (Live)
17:00–18:00 Wrap-up, discussion & strategic outlook for innovators and regional authorities — PRECISEU Coordination (Live)
Monday, 8 June 2026 (14:00 – 18:00 CET)
Monday, 8 June 2026 (14:00 – 18:00 CET)
The fourth day will focus on European testing infrastructures, AI Factories, digital twins, translational laboratories, supercomputing, and emerging tools supporting data-intensive personalised medicine and ATMP implementation across Europe.
The fourth day will focus on European testing infrastructures, AI Factories, digital twins, translational laboratories, supercomputing, and emerging tools supporting data-intensive personalised medicine and ATMP implementation across Europe.
14:00 Welcome & recap — PRECISEU Coordination (Live)
14:10 TEF-Health testing and experimentation facilities — access to European infrastructures for healthcare innovation — TEF-Health (Online)
14:35 BioRed Lab — overview and live demonstrations (Part 1) — Health & Life Sciences Cluster Bulgaria (Live)
15:20 Short break
15:30 BioRed Lab — overview and live demonstrations (Part 2) — Health & Life Sciences Cluster Bulgaria (Live)
16:00 Bulgarian AI Factory BRAIN++ and Discoverer++ supercomputer for personalised medicine and health-data projects — BRAIN++ (Live)
16:25 Virtual human physiology and digital twins in healthcare — Sabato Mellone · Marco Viceconti (Online)
16:55 Financial models for molecular biomarkers and value-based personalised medicine — AstraZeneca (TBC) (Online)
17:20 “Advancing Personalised Medicine: Mapping Europe’s Readiness for ATMP Delivery and Development” — David Morrow (Live)
17:45–18:00 Wrap-up & Q&A — PRECISEU Coordination (Live)
14:00 Welcome & recap — PRECISEU Coordination (Live)
14:10 TEF-Health testing and experimentation facilities — access to European infrastructures for healthcare innovation — TEF-Health (Online)
14:35 BioRed Lab — overview and live demonstrations (Part 1) — Health & Life Sciences Cluster Bulgaria (Live)
15:20 Short break
15:30 BioRed Lab — overview and live demonstrations (Part 2) — Health & Life Sciences Cluster Bulgaria (Live)
16:00 Bulgarian AI Factory BRAIN++ and Discoverer++ supercomputer for personalised medicine and health-data projects — BRAIN++ (Live)
16:25 Virtual human physiology and digital twins in healthcare — Sabato Mellone · Marco Viceconti (Online)
16:55 Financial models for molecular biomarkers and value-based personalised medicine — AstraZeneca (TBC) (Online)
17:20 “Advancing Personalised Medicine: Mapping Europe’s Readiness for ATMP Delivery and Development” — David Morrow (Live)
17:45–18:00 Wrap-up & Q&A — PRECISEU Coordination (Live)
Tuesday, 9 June 2026 (12:00 – 18:00 CET)
Tuesday, 9 June 2026 (12:00 – 18:00 CET)
The final day will focus on intellectual property, technology transfer, genomics, regulatory science, gene therapies, and future skills needed to accelerate the implementation and scalability of personalised medicine across Europe.
The final day will focus on intellectual property, technology transfer, genomics, regulatory science, gene therapies, and future skills needed to accelerate the implementation and scalability of personalised medicine across Europe.
12:00 Welcome & recap of the week — PRECISEU Coordination (Live)
12:10 EMA session (Part 1) — Sebastian Asprella (Live)
13:00 Coffee break
13:20 EMA session (Part 2) — Sebastian Asprella (Live)
14:10 PerfeTTO life sciences technology transfer network and AI-enabled TT platforms — PerfeTTO Network (Online)
14:40 IPR challenges in health data, ATMPs, and omics-related projects — Patent Office of the Republic of Bulgaria (Online)
15:10 1 Million Genomes Initiative — Radka Kaneva (Live)
15:35 Break
15:45 Future Skills for Personalised Medicine and healthcare workforce transformation — Ioanna Tsea · Claire Naissett (Online)
16:20 Access to gene therapies and challenges in advanced treatments — Antoine Heron (Online)
16:50 ROGEN genomic research infrastructure and integration into personalised medicine pathways — Bogdan Tamba (Live)
17:20–17:30 Final wrap-up, key takeaways and next steps — PRECISEU Coordination (Live)
12:00 Welcome & recap of the week — PRECISEU Coordination (Live)
12:10 EMA session (Part 1) — Sebastian Asprella (Live)
13:00 Coffee break
13:20 EMA session (Part 2) — Sebastian Asprella (Live)
14:10 PerfeTTO life sciences technology transfer network and AI-enabled TT platforms — PerfeTTO Network (Online)
14:40 IPR challenges in health data, ATMPs, and omics-related projects — Patent Office of the Republic of Bulgaria (Online)
15:10 1 Million Genomes Initiative — Radka Kaneva (Live)
15:35 Break
15:45 Future Skills for Personalised Medicine and healthcare workforce transformation — Ioanna Tsea · Claire Naissett (Online)
16:20 Access to gene therapies and challenges in advanced treatments — Antoine Heron (Online)
16:50 ROGEN genomic research infrastructure and integration into personalised medicine pathways — Bogdan Tamba (Live)
17:20–17:30 Final wrap-up, key takeaways and next steps — PRECISEU Coordination (Live)
Event background
Event background
The PRECISEU Personalised Medicine (PM) School is aiming to advance personalised healthcare across Europe. Held annually, the school delivers intensive training to scientists, entrepreneurs, and policymakers, aligning its week-long sessions with major project milestones.
The curriculum draws directly from PRECISEU’s research outcomes, developed in collaboration with expert teams and regional partners, and it ensures up-to-date and locally relevant content, covering various areas
health data
advanced therapies
innovation management.
A hybrid format – combining in-person and online modules – broadens access and reduces participation costs.
Inspired by Biocat’s successful short programs, the PM School targets professionals seeking practical skills in healthcare innovation. It also features a strong mentoring component, helping participants refine and advance their projects toward market readiness through partnerships with accelerators and regional initiatives.
By fostering collaboration and skill development, the PRECISEU PM School strengthens Europe’s health innovation ecosystem and supports the shift toward more personalised, efficient care.
Language: English
Audience: Researchers, innovators, clinicians, policymakers, students, and industry stakeholders.
Language: English
Audience: Researchers, innovators, clinicians, policymakers, students, and industry stakeholders.
Participants who take part in at least three of the five sessions will receive a certificate acknowledging their dedication to learning and expanding their insights in personalised medicine.
Participants who take part in at least three of the five sessions will receive a certificate acknowledging their dedication to learning and expanding their insights in personalised medicine.
Venue: 5-9 June 2026
Venue: 5-9 June 2026
Sofia Urban Living Lab
📬 Address: 1 Serdika Str., 3rd Floor, 1000 Sofia, Bulgaria
🏢 About: Sofia's open innovation ecosystem & Urban Living Lab. Hosts workshops, hackathons & research events.
Join us to shape the next generation of Personalised Medicine in Europe!
Join us to shape the next generation of Personalised Medicine in Europe!
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.
Speaker form
Page updated
Report abuse